The purpose of this study is to determine if the investigational drug bis-POM PMEA is safe to administer to people infected with HIV who have a CD4+ cell count. This study will also seek to identify if bis-POM PMEA helps slow the progression of HIV and if bis-POM PMEA helps those infected live longer. The study will also look to determine if those not infected with CMV can remain free of disease.
Showing the most recent 10 out of 211 publications